BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 38269764)

  • 21. Toward a normalized clinical drug knowledge base in China-applying the RxNorm model to Chinese clinical drugs.
    Wang L; Zhang Y; Jiang M; Wang J; Dong J; Liu Y; Tao C; Jiang G; Zhou Y; Xu H
    J Am Med Inform Assoc; 2018 Jul; 25(7):809-818. PubMed ID: 29635469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilizing RxNorm to support practical computing applications: capturing medication history in live electronic health records.
    Bennett CC
    J Biomed Inform; 2012 Aug; 45(4):634-41. PubMed ID: 22426081
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Automatic Identification of Individual Drugs in Death Certificates.
    Kho SJ; Sheth A; Bodenreider O
    Stud Health Technol Inform; 2019 Aug; 264():183-187. PubMed ID: 31437910
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Normalized names for clinical drugs: RxNorm at 6 years.
    Nelson SJ; Zeng K; Kilbourne J; Powell T; Moore R
    J Am Med Inform Assoc; 2011; 18(4):441-8. PubMed ID: 21515544
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Standardizing drug adverse event reporting data.
    Wang L; Jiang G; Li D; Liu H
    Stud Health Technol Inform; 2013; 192():1101. PubMed ID: 23920875
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An alternative database approach for management of SNOMED CT and improved patient data queries.
    Campbell WS; Pedersen J; McClay JC; Rao P; Bastola D; Campbell JR
    J Biomed Inform; 2015 Oct; 57():350-7. PubMed ID: 26305513
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RxNorm for drug name normalization: a case study of prescription opioids in the FDA adverse events reporting system.
    Le H; Chen R; Harris S; Fang H; Lyn-Cook B; Hong H; Ge W; Rogers P; Tong W; Zou W
    Front Bioinform; 2023; 3():1328613. PubMed ID: 38250436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. iDISK: the integrated DIetary Supplements Knowledge base.
    Rizvi RF; Vasilakes J; Adam TJ; Melton GB; Bishop JR; Bian J; Tao C; Zhang R
    J Am Med Inform Assoc; 2020 Apr; 27(4):539-548. PubMed ID: 32068839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profiling structured product labeling with NDF-RT and RxNorm.
    Zhu Q; Jiang G; Chute CG
    J Biomed Semantics; 2012 Dec; 3(1):16. PubMed ID: 23256517
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RxTerms - a drug interface terminology derived from RxNorm.
    Fung KW; McDonald C; Bray BE
    AMIA Annu Symp Proc; 2008 Nov; 2008():227-31. PubMed ID: 18998891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Normalizing Dietary Supplement Product Names Using the RxNorm Model.
    Vasilakes J; Fan Y; Rizvi R; Bompelli A; Bodenreider O; Zhang R
    Stud Health Technol Inform; 2019 Aug; 264():408-412. PubMed ID: 31437955
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MedXN: an open source medication extraction and normalization tool for clinical text.
    Sohn S; Clark C; Halgrim SR; Murphy SP; Chute CG; Liu H
    J Am Med Inform Assoc; 2014; 21(5):858-65. PubMed ID: 24637954
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Building a drug ontology based on RxNorm and other sources.
    Hanna J; Joseph E; Brochhausen M; Hogan WR
    J Biomed Semantics; 2013 Dec; 4(1):44. PubMed ID: 24345026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of RxNorm for Medication Clinical Decision Support.
    Freimuth RR; Wix K; Zhu Q; Siska M; Chute CG
    AMIA Annu Symp Proc; 2014; 2014():554-63. PubMed ID: 25954360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using the RxNorm web services API for quality assurance purposes.
    Peters L; Bodenreider O
    AMIA Annu Symp Proc; 2008 Nov; 2008():591-5. PubMed ID: 18999038
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methods for managing variation in clinical drug names.
    Peters L; Kapusnik-Uner JE; Bodenreider O
    AMIA Annu Symp Proc; 2010 Nov; 2010():637-41. PubMed ID: 21347056
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Achieving standardized medication data in clinical research studies: two approaches and applications for implementing RxNorm.
    Richesson RL; Smith SB; Malloy J; Krischer JP
    J Med Syst; 2010 Aug; 34(4):651-7. PubMed ID: 20703919
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Integrating historical clinical and financial data for pharmacological research.
    Deshmukh VG; Sower NB; Hunter CY; Mitchell JA
    BMC Med Res Methodol; 2011 Nov; 11():151. PubMed ID: 22099213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cross-domain targeted ontology subsets for annotation: the case of SNOMED CORE and RxNorm.
    López-García P; Lependu P; Musen M; Illarramendi A
    J Biomed Inform; 2014 Feb; 47():105-11. PubMed ID: 24095962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.